Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers. Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers
收藏NIAID Data Ecosystem2026-05-01 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA971167
下载链接
链接失效反馈官方服务：
资源简介：
To investigate in situ-in vitro molecular correspondence and the relationship between in vitro and patient response to temozolomide (TMZ) Overall design: Gene expression profiling analysis using data obtained from RNA-seq of 24 different GBM cell cultures
创建时间：
2023-05-10
